Similar articles

• Adverse allergic reaction to technetium-99m methylene diphosphonate.

  Spicer JA, Preston DF, Stephens RL. Spicer JA, et al. J Nucl Med. 1985 Apr;26(4):373-4. J Nucl Med. 1985. PMID: 2984362
• Long-lasting dermatological lesions after tiludronate therapy.

  Roux C, Listrat V, Villette B, Lessana-Leibowitch M, Ethgen D, Pelissier C, Dougados M, Amor B. Roux C, et al. Calcif Tissue Int. 1992 Apr;50(4):378-80. doi: 10.1007/BF00301637. Calcif Tissue Int. 1992. PMID: 1571850 No abstract available.
• Severe reaction to diphosphonate: implications for treatment of Paget's disease.

  Elliott AT, Murray T, Mackie RM, Hunter JA. Elliott AT, et al. BMJ. 1988 Sep 3;297(6648):592-3. doi: 10.1136/bmj.297.6648.592-a. BMJ. 1988. PMID: 3139224 Free PMC article. No abstract available.
• Atypical Femur Fractures Associated With Diphosphonate Use.

  Balach T, Baldwin PC, Intravia J. Balach T, et al. J Am Acad Orthop Surg. 2015 Sep;23(9):550-7. doi: 10.5435/JAAOS-D-14-00024. Epub 2015 Jul 20. J Am Acad Orthop Surg. 2015. PMID: 26195566 Review.
• [Diphosphonate therapy and osteonecrosis of the jaw].

  Løkken P, Skoglund LA, Skjelbred P. Løkken P, et al. Tidsskr Nor Laegeforen. 2007 Aug 9;127(15):1945-7. Tidsskr Nor Laegeforen. 2007. PMID: 17700737 Review. Norwegian. No abstract available.